Connecticut legislation · 2026 General Assembly
Connecticut SB191: AN ACT CONCERNING THE PSYCHEDELIC-ASSISTED THERAPY PILOT PROGRAM.
Status: Signed into law, June 4, 2026
What the bill says
An act concerning the psychedelic-assisted therapy pilot program. assembly convened.
From the enrolled text:
AN ACT CONCERNING THE PSYCHEDELIC-ASSISTED THERAPY PILOT PROGRAM. Assembly convened: Section 1. Section 17a-484g of the general statutes is repealed and the following is substituted in lieu thereof (Effective July 1, 2026): (a) As used in this section: (1) "MDMA" means the synthetic psychoactive drug, 3,4methylenedioxymethamphetamine, commonly known as ecstasy or molly, that acts as a serotonin receptor agonist and reuptake inhibitor of serotonin and dopamine. (2) "Psilocybin" means a serotonin receptor agonist that occurs naturally in some mushroom species. (3) "Qualified patient" means an individual who is eighteen years of age or older and meets clinical eligibility criteria established by the institutional review board of the medical school selected to administer the pilot program under subsection (b) of this section, including, but not limited to, a resident of the state who is (A) a veteran, (B) a retired first responder, or (C) a direct care health care worker. Senate Bill No. 191 (b) [Not later than January 1, 2023, the] The Department of Mental Health and Addiction Services shall establish, within available appropriations, a psychedelic-assisted therapy pilot program, to be administered by a medical school in the state. Such pilot program shall provide qualified patients with MDMA-assisted or psilocybin-assisted therapy as part of a research program approved by the federal Food and Drug Administration pursuant to 21 CFR 312, …
Sponsors
- Martha Marx (D, 20) · primary sponsor
- Aundre Bumgardner (D, 41)
- Devin Carney (R, 23)
- Nicholas Gauthier (D, 38)
- Hubert Delany (D, 144)
- Kenneth Gucker (D, 138)
- Nicole Klarides-Ditria (R, 105)
Latest actions
- : Signed by the Governor
- : Transmitted by Secretary of the State to Governor
- : Transmitted to the Secretary of State
- : Public Act 26-108
- : In Concurrence
- : House Passed
- : House Calendar Number 378
- : Favorable Report, Tabled for the Calendar, House
- : Senate Passed
- : File Number 28
Votes
- House Roll Call 288 (May 6, 2026): 122 yea, 27 nay, passed
- Senate Roll Call 98 (April 8, 2026): 35 yea, 0 nay, passed
- PH Vote Tally Sheet (Joint Favorable) (March 2, 2026): 23 yea, 8 nay, passed
Subjects: Drugs
Common questions
- What is SB191?
- SB191 is a bill in the Connecticut Legislature (2026 General Assembly): AN ACT CONCERNING THE PSYCHEDELIC-ASSISTED THERAPY PILOT PROGRAM.
- What does SB191 do?
- In its own words: An act concerning the psychedelic-assisted therapy pilot program. assembly convened.
- What is the status of SB191?
- Signed into law as of June 4, 2026. Latest action: Signed by the Governor (June 4, 2026).
- Who sponsored SB191?
- Martha Marx (D, 20), with 6 co-sponsors.
- Where is the official record for SB191?
- On the Connecticut Legislature website: https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00191&which_year=2026
Source: official Connecticut record. Tracked by Delilah, AI for legislation across all 50 states and Congress.